These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3545157)

  • 1. A clinical review of calcium antagonists in acute myocardial infarction.
    Kendall MJ; Horton RC
    Arq Bras Cardiol; 1986 Jan; 46(1):53-8. PubMed ID: 3545157
    [No Abstract]   [Full Text] [Related]  

  • 2. [Calcium antagonists in acute myocardial infarction].
    Lotto A; Massari FM; Bertoni T; Ambrosini F; Finzi A; Foresti A; Valentini R; Matta F
    G Ital Cardiol; 1988 Nov; 18(11):974-81. PubMed ID: 3073992
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].
    Sakai M; Ueda K; Nakahara K; Tsuchimochi H; Mutsushita S; Kuramoto K; Murakami M
    Kokyu To Junkan; 1985 Feb; 33(2):159-64. PubMed ID: 4001593
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium channel blockers in the management of myocardial infarction patients.
    Gheorghiade M
    Henry Ford Hosp Med J; 1991; 39(3-4):210-6. PubMed ID: 1804826
    [No Abstract]   [Full Text] [Related]  

  • 7. From beta blockers to Ca2+ blockers in hypertension: a review.
    Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Jul; 18(7):735-9. PubMed ID: 6125488
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats.
    Kaur AH; Singh M; Singh J; Jain K
    Indian J Exp Biol; 1985 Jan; 23(1):31-4. PubMed ID: 4018848
    [No Abstract]   [Full Text] [Related]  

  • 9. The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons.
    Alps BJ; Calder C; Wilson A
    Arzneimittelforschung; 1983; 33(6):868-76. PubMed ID: 6684443
    [No Abstract]   [Full Text] [Related]  

  • 10. Are calcium antagonists cardioprotective?
    Kendall MJ; Horton RC
    J R Coll Physicians Lond; 1985 Apr; 19(2):85-9. PubMed ID: 3889321
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium channel blockers: an evidence-based review.
    Waters D
    Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Ca2+ antagonists on coronary circulation].
    Kajiwara N; Nagao T; Kanmatsuse K; Suzuki T; Emoto H; Kotani T
    Nihon Rinsho; 1989 Aug; 47(8):1764-9. PubMed ID: 2585738
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy with calcium antagonists in acute myocardial infarction. Hemodynamic evaluation using the hand-grip test].
    Ravazzi PA; Ivaldi M; Priolo C; Fornari P; Carosio G; Provera PF; Guarraggi F
    Minerva Cardioangiol; 1986; 34(7-8):511-6. PubMed ID: 3774166
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium channel blockers.
    Dipalma JR
    Am Fam Physician; 1983 Feb; 27(2):283-5. PubMed ID: 6829383
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
    Just H; Frey M
    Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers: rationale for their clinical use.
    Conti CR
    J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992
    [No Abstract]   [Full Text] [Related]  

  • 18. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism(s) of calcium antagonists and ischemia.
    Hugenholtz PG; de Jong JW
    Z Kardiol; 1984; 73 Suppl 2():89-93. PubMed ID: 6528706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of corinfar and finoptin on lipid peroxidation].
    Zhuravlev AK; Murashko VV; Kamchatnov PR
    Klin Med (Mosk); 1988 Apr; 66(4):35-7. PubMed ID: 3398447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.